The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other complications before using any product.
In the United States, CBD itself is not specifically listed in the United States Controlled Substances Act like the psychoactive compound, tetrahydrocannabinol (THC). The US government, which specifies which parts of cannabis plants are prohibited, excludes hemp’s “mature stalks” and “oil or cake made from the seeds” and “sterilized seeds” from its definition of “marihuana.”
Schizophrenia. Research on the use of cannabidiol for psychotic symptoms in people with schizophrenia is conflicting. Some early research suggests that taking cannabidiol four times daily for 4 weeks improves psychotic symptoms and might be as effective as the antipsychotic medication amisulpride. However, other early research suggests that taking cannabidiol for 14 days is not beneficial. The conflicting results might be related to the cannabidiol dose used and duration of treatment.
CBD plays a major role in the immune system modulation which basically means that it helps in auto-immune conditions such as rheumatoid arthritis. Rheumatoid arthritis is a chronic progressive disease which causes inflammation in joints, resulting in painful deformity, and at times immobility in the fingers, feet, wrists, and ankles. Because to it’s anti inflammatory effects, CBD oil provides relief of joint pain caused by rheumatoid arthritis, and can also decrease joint destruction.

In practice, selling CBD seems to be legally riskier than possessing it. The DEA’s priority seems mostly to concern commercial violations; most cases involved smoke shops and non-cannabis vape stores selling CBD cartridges. In 2015, police seized CBD cartridges at a vape store near Milwaukee, but the store owners were never arrested or charged. (A 2014 law made it legal for patients to possess and use CBD oil in Wisconsin, but the law did not make it legal to sell.) That same year, police in central Florida arrested the owner of a local smoke shop chain for selling CBD products. 

This is exciting for many, but also complicated due to the fact that possession of marijuana is still considered a criminal offense at the federal law level. Flying across and transporting marijuana across state lines, drug tests for employees following a visit to one of the states where marijuana is legal and other complications have led many to avoid the topic – and consumption – altogether.
CBD oil has gained the most traction among the general public for its ability to treat psychiatric conditions like anxiety and addiction. The roots of CBD oil in psychological treatment originated from its surprising effectiveness at helping children with epilepsy, and it’s becoming increasingly popular as a way to help ameliorate symptoms in children with autism spectrum disorder as well.
Regular dosage size is recommended at 20 drops, 1-2 times per day. According to the manufacturer, small to large dosage sizes are as follows: 250 mg = 1/4 dropper, or ~5 drops 300 mg = 3/10 dropper, or ~6 drops 500 mg = 1/2 dropper, or ~10 drops 600 mg = 3/5 dropper, or ~12 drops 800 mg = 4/5 dropper, or ~16 drops 1000 mg = 1 full dropper, or ~20 drops 1500 mg = 1 1/2 dropper, or ~30 drops
When it comes to buying CBD oil, you must be exceedingly cautious because there is a tremendous amount of misinformation and outright deceit within the industry. Many online resources may try to mislead you for profit or other disingenuous reasons. For instance, some Cannabidiol oil companies advertise that their products contain a specific concentration of CBD (displayed in either percentages or milligrams (mg). However, independent research has shown that many of these sellers and their products do not live up to their claims as their products contain far less CBD than they state in print. The Food and Drug Administration (FDA) issued warning letters to specific companies in 2016 because their products were found to contain far less CBD than advertised.
×